Synapse being sold to CA-based BioMarin
Guest ContributorJanuary 23, 2002
Vancouver’s Synapse Technologies Inc is being acquired by BioMarin Pharmaceutical Inc, Novato CA for $15.9 million and up to $8 million contingent of certain development milestones. BioMarin will use Synapse’s technology to deliver therapeutics enzymes to the brain for treatment of lysosomal storage disorders. Synapse’s technology was originally developed by Dr Wilfred Jeffries of the Univ of British Columbia and the firm has been supported by several Canadian venture capital firms. BioMarin recently received follow-on public financing of US$96 million....
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.